Bokf, Na Bio Techne Corp Transaction History

Bokf, Na

  • $5.65 Billion
  • Q3 2024

A detailed history of Bokf, Na transactions in Bio Techne Corp stock. As of the latest transaction made, Bokf, Na holds 72 shares of TECH stock, worth $5,258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72
Previous 71 1.41%
Holding current value
$5,258
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$70.96 - $82.35 $70 - $82
1 Added 1.41%
72 $5,000
Q2 2024

Aug 07, 2024
BUY
$62.12 - $84.15 $4,162 - $5,638
67 Added 1675.0%
71 $5,000
Q1 2023

May 11, 2023
BUY
$71.62 - $86.62 $286 - $346
4 New
4 $0
Q2 2022

Aug 11, 2022
SELL
$322.67 - $449.65 $290,725 - $405,134
-901 Reduced 37.29%
1,515 $525,000
Q1 2022

May 13, 2022
BUY
$353.85 - $487.79 $350,665 - $483,399
991 Added 69.54%
2,416 $1.05 Million
Q4 2021

Mar 11, 2022
BUY
$456.15 - $525.06 $50,632 - $58,281
111 Added 8.45%
1,425 $737,000
Q3 2021

Nov 10, 2021
SELL
$444.87 - $538.88 $38,258 - $46,343
-86 Reduced 6.14%
1,314 $637,000
Q1 2021

Apr 21, 2021
SELL
$314.62 - $411.0 $49,080 - $64,116
-156 Reduced 10.03%
1,400 $534,000
Q4 2020

Feb 12, 2021
SELL
$246.9 - $321.87 $155,053 - $202,134
-628 Reduced 28.75%
1,556 $494,000
Q3 2020

Oct 30, 2020
SELL
$232.22 - $282.96 $62,699 - $76,399
-270 Reduced 11.0%
2,184 $541,000
Q2 2020

Aug 12, 2020
BUY
$185.43 - $279.56 $246,621 - $371,814
1,330 Added 118.33%
2,454 $648,000
Q1 2020

May 13, 2020
BUY
$161.17 - $221.51 $181,155 - $248,977
1,124 New
1,124 $213,000

Others Institutions Holding TECH

# of Institutions
602
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email